Pharmacodynamics Study of Enoxalow, Produced by Blau Farmaceutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmaceutica Ltda, in Healthy Subjects After Intravenous Administration.

Trial Profile

Pharmacodynamics Study of Enoxalow, Produced by Blau Farmaceutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmaceutica Ltda, in Healthy Subjects After Intravenous Administration.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2016

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Blood coagulation disorders; Deep vein thrombosis; Embolism; Myocardial infarction; Thromboembolism; Unstable angina pectoris
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top